FDA 483 - Mars Fishcare North America, Inc. - April 07, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Mars Fishcare North America, Inc. in Chalfont, PA, a veterinary drug manufacturer, was cited for six observations during an FDA inspection. The inspection revealed significant deficiencies in laboratory controls, including inadequate OOS investigations, insufficient active ingredient testing, and unqualified reference standards. Additionally, issues were noted with equipment design, cleaning validation, and computer system audit trail reviews, indicating a broad lack of adherence to GMP regulations.
ID · 2fef26d4-999e-4944-800c-d02e6c28cd6d